Brain stimulation for hard-to-treat Tourette's syndrome
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a brain stimulation device (RNS) for people with Tourette's syndrome whose symptoms haven't improved with standard treatments. It aims to see if this approach can reduce tics and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with Tourette's syndrome by a doctor.
- Your tics are severe (score of 35 or higher on a standard tic scale) and have been for at least a year.
- You have tried at least three different types of medication for three months or more, and they didn't help enough.
- Behavioral therapy is not an option for you or hasn't worked.
- You have no other major mental health conditions and no suicidal thoughts for at least six months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgical procedure using deep brain stimulation to treat severe Tourette syndrome that hasn't improved with other treatments. It may help reduce tics by targeting specific areas in the brain.
This study looks at brain activity in people with Tourette syndrome who are already receiving deep brain stimulation (a treatment that uses electrical pulses to help control tics). The goal is to learn more about the brain signals linked to tics, which could help improve future treatments.
This trial tests whether low-intensity ultrasound waves aimed at specific brain areas can reduce tics in people with Tourette syndrome. It's a first-in-human study to see if this non-invasive approach is safe and effective.
This trial tests whether a treatment called TMS, added to an evidence-based therapy called CBIT, can reduce Tourette’s tics more than CBIT alone. You may be assigned to different study groups, and they will also use brain imaging to measure changes.
This Phase 2 trial tests SCI-110 to reduce Tourette syndrome tics. It may help people whose tics are moderate to severe while they take the study medicine and continue (or keep steady) their usual tic treatments.
This study tests whether combining a brain stimulation technique called TMS with behavioral therapy can reduce tics in adolescents and young adults. If you have had tics for at least a year and they are moderate or severe, this trial may be a good fit.
Hear when a new Tourette Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.